Highbridge Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Highbridge Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-28,170	Closed	-$397K	–	2056
2017 Q3	$397K	Buy	+28,170	New	+$255K	0.01%	1063
2017 Q2	–	Sell	-165,890	Closed	-$1.08M	–	1699
2017 Q1	$1.08M	Buy	+165,890	New	+$928K	0.02%	598
2016 Q1	–	Sell	-81,704	Closed	-$492K	–	1885
2015 Q4	$492K	Buy	81,704 +5,782	+8%	+$33.1K	0.01%	997
2015 Q3	$454K	Buy	+75,922	New	+$527K	0.01%	1063
2015 Q1	–	Sell	-76,413	Closed	-$529K	–	1636
2014 Q4	$529K	Buy	+76,413	New	+$562K	0.01%	804

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Highbridge Capital Management's SPPI Position: Q4 2017 in Review

Highbridge Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2017, closing a stake of 28,170 shares — an estimated $397K sold.

Highbridge Capital Management first reported a position in SPPI in Q4 2014 and held it in 5 quarters. The position peaked at $1.08M in Q1 2017. 157 funds tracked by Wall St. Rank hold SPPI as of Q4 2017.

Highbridge Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
Highbridge Capital Management sold 28,170 Spectrum Pharmaceuticals Inc shares in Q4 2017, an estimated $397K.
Highbridge Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 5 quarters.
Highbridge Capital Management's Spectrum Pharmaceuticals Inc position peaked at $1.08M in Q1 2017.
157 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2017.

Based on Highbridge Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.